Healthcare policy & drug development (The Cambridge Judge Business Debate podcast series)
Duration: 38 mins 20 secs
Share this media item:
Embed this media item:
Embed this media item:
About this item
| Description: | How ageing societies can afford healthcare for all and reform an organisational system that has not kept pace with technology. |
|---|
| Created: | 2019-03-13 18:14 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collection: | The Cambridge Judge Business Debate | ||||||||||||
| Publisher: | University of Cambridge | ||||||||||||
| Copyright: | University of Cambridge | ||||||||||||
| Language: | eng (English) | ||||||||||||
| Keywords: | health; healthcare; Drug discovery; Hospitals; public services; | ||||||||||||
| Credits: |
|
||||||||||||
| Abstract: | In this episode, joining podcast host Michael Kitson, University Senior Lecturer in International Macroeconomics at Cambridge Judge Business School, are Cambridge Judge faculty Kamal Munir, Reader in Strategy & Policy; Stefan Scholtes, Dennis Gillings Professor of Health Management; Aris Oraiopoulos, University Lecturer in Operations Management; and Paul Tracey, Professor of Innovation & Organisation.
This is the 11th in a series of “Cambridge Judge Business Debate” podcasts featuring faculty and others associated with Cambridge Judge Business School and the broader Cambridge community. This latest podcast focuses on healthcare policy – how can ageing societies pay for healthcare, reform a hospital system highly resistant to change, and develop new medicines in a cost-efficient manner. |
|---|---|